161 related articles for article (PubMed ID: 9875401)
1. Targeting RNase L to human immunodeficiency virus RNA with 2-5A-antisense.
Player MR; Maitra RK; Silverman RH; Torrence PF
Antivir Chem Chemother; 1998 May; 9(3):225-31. PubMed ID: 9875401
[TBL] [Abstract][Full Text] [Related]
2. Targeting RNA decay with 2',5' oligoadenylate-antisense in respiratory syncytial virus-infected cells.
Cirino NM; Li G; Xiao W; Torrence PF; Silverman RH
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1937-42. PubMed ID: 9050883
[TBL] [Abstract][Full Text] [Related]
3. Correlation of selective modifications to a 2',5'-oligoadenylate-3',5'-deoxyribonucleotide antisense chimera with affinity for the target nucleic acid and with ability to activate RNase L.
Xiao W; Li G; Maitra RK; Maran A; Silverman RH; Torrence PF
J Med Chem; 1997 Apr; 40(8):1195-200. PubMed ID: 9111293
[TBL] [Abstract][Full Text] [Related]
4. 2-5A-DNA conjugate inhibition of respiratory syncytial virus replication: effects of oligonucleotide structure modifications and RNA target site selection.
Barnard DL; Sidwell RW; Xiao W; Player MR; Adah SA; Torrence PF
Antiviral Res; 1999 Apr; 41(3):119-34. PubMed ID: 10320045
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of double-headed 2-5A-antisense chimeras and their ability to activate human RNase L.
Ueno Y; Okatani S; Yamada Y; Kitade Y
Bioorg Med Chem Lett; 2003 Nov; 13(22):3959-61. PubMed ID: 14592484
[TBL] [Abstract][Full Text] [Related]
6. Catalytic cleavage of an RNA target by 2-5A antisense and RNase L.
Maitra RK; Li G; Xiao W; Dong B; Torrence PF; Silverman RH
J Biol Chem; 1995 Jun; 270(25):15071-5. PubMed ID: 7797490
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of the antisense oligonucleotides carrying the modified 2-5A molecules at their 5'-termini and their properties.
Ueno Y; Kato Y; Okatani S; Kitade Y
Nucleic Acids Res Suppl; 2002; (2):45-6. PubMed ID: 12903097
[TBL] [Abstract][Full Text] [Related]
8. 2',5'-Oligoadenylate-antisense chimeras cause RNase L to selectively degrade bcr/abl mRNA in chronic myelogenous leukemia cells.
Maran A; Waller CF; Paranjape JM; Li G; Xiao W; Zhang K; Kalaycio ME; Maitra RK; Lichtin AE; Brugger W; Torrence PF; Silverman RH
Blood; 1998 Dec; 92(11):4336-43. PubMed ID: 9834240
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of antisense oligonucleotides carrying modified 2-5A molecules at their 5'-termini and their properties.
Ueno Y; Kato Y; Okatani S; Ishida N; Nakanishi M; Kitade Y
Bioconjug Chem; 2003; 14(3):690-6. PubMed ID: 12757397
[TBL] [Abstract][Full Text] [Related]
10. Controlling gene expression with 2-5A antisense.
Leaman DW; Cramer H
Methods; 1999 Jul; 18(3):252-65. PubMed ID: 10454983
[TBL] [Abstract][Full Text] [Related]
11. Targeting RNA for degradation with a (2'-5')oligoadenylate-antisense chimera.
Torrence PF; Maitra RK; Lesiak K; Khamnei S; Zhou A; Silverman RH
Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1300-4. PubMed ID: 7679499
[TBL] [Abstract][Full Text] [Related]
12. Potent inhibition of respiratory syncytial virus replication using a 2-5A-antisense chimera targeted to signals within the virus genomic RNA.
Player MR; Barnard DL; Torrence PF
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8874-9. PubMed ID: 9671772
[TBL] [Abstract][Full Text] [Related]
13. Nuclease-resistant composite 2',5'-oligoadenylate-3', 5'-oligonucleotides for the targeted destruction of RNA: 2-5A-iso-antisense.
Xiao W; Li G; Player MR; Maitra RK; Waller CF; Silverman RH; Torrence PF
J Med Chem; 1998 Apr; 41(9):1531-9. PubMed ID: 9554886
[TBL] [Abstract][Full Text] [Related]
14. Blockage of NF-kappa B signaling by selective ablation of an mRNA target by 2-5A antisense chimeras.
Maran A; Maitra RK; Kumar A; Dong B; Xiao W; Li G; Williams BR; Torrence PF; Silverman RH
Science; 1994 Aug; 265(5173):789-92. PubMed ID: 7914032
[TBL] [Abstract][Full Text] [Related]
15. Selective RNA cleavage by isolated RNase L activated with 2-5A antisense chimeric oligonucleotides.
Silverman RH; Dong B; Maitra RK; Player MR; Torrence PF
Methods Enzymol; 2000; 313():522-33. PubMed ID: 10595377
[No Abstract] [Full Text] [Related]
16. Solid-phase synthesis of 5'-triphosphate 2'-5'-oligoadenylates analogs with 3'-O-biolabile groups and their evaluation as RNase L activators and antiviral drugs.
Thillier Y; Stevens SK; Moy C; Taylor J; Vasseur JJ; Beigelman L; Debart F
Bioorg Med Chem; 2013 Sep; 21(17):5461-9. PubMed ID: 23810677
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of double-headed 2-5A-antisense chimeras and their ability to activate human RNase L.
Ueno Y; Okatani S; Yamada Y; Kitade Y
Nucleic Acids Res Suppl; 2003; (3):63-4. PubMed ID: 14510381
[TBL] [Abstract][Full Text] [Related]
18. Targeted therapy of respiratory syncytial virus in African green monkeys by intranasally administered 2-5A antisense.
Leaman DW; Longano FJ; Okicki JR; Soike KF; Torrence PF; Silverman RH; Cramer H
Virology; 2002 Jan; 292(1):70-7. PubMed ID: 11878909
[TBL] [Abstract][Full Text] [Related]
19. 2-5A-antisense chimeras: inhibitors of respiratory syncytial virus infection.
Torrence PF
Curr Opin Mol Ther; 1999 Jun; 1(3):307-15. PubMed ID: 11713795
[TBL] [Abstract][Full Text] [Related]
20. Delivery of 2-5A cargo into living cells using the Tat cell penetrating peptide: 2-5A-tat.
Zhou L; Thakur CS; Molinaro RJ; Paranjape JM; Hoppes R; Jeang KT; Silverman RH; Torrence PF
Bioorg Med Chem; 2006 Dec; 14(23):7862-74. PubMed ID: 16908165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
